Fluticasone Propionate Nebulized Suspension Trial for Infant Wheezing Shows Potential
A clinical trial is underway to evaluate the efficacy and safety of fluticasone propionate nebulized suspension in infants with acute wheezing.
Asset / Drug
Drug and asset intelligence for Budesonide with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.